drugset / Trial / NCT01712451

Dose-ranging Study

NCT01712451

Phase 2 Completed 200 enrolled Neothetics, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dose ranging study

Timeline

Start
2011-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified
Subject salmeterol xinafoate Unknown

Indications

No indication recorded.